No Prescription |
 |
 | ||
|
Curam Suspension Augmentin |
|
| ||
No Prescription » Prescription Drugs 5 » Curam Suspension Augmentin Syrup 125 Each 5mL contains potassium clavulanate/amoxycillin trihydrate equivalent to 31.25mg clavulanic acid/125mg amoxycillinCuram is an antibiotic used to treat infections in different parts of the body caused by bacteria. Curam will not work against infections caused by viruses such as colds or the flu.Curam is also used to prevent infection from major surgery.Curam is an antibiotic that belongs to a group of medicines called penicillins. These antibiotics work by killing the bacteria that are causing your infection.How to use Curam OralShake the bottle well before each dose. Take this medication by mouth with a meal or snack usually every 8 or 12 hours or as directed by the doctor.Antibiotics work best when the amount of medicine in your body is kept at a constant level. Therefore take this drug at evenly spaced intervals.Continue to take this medication until the full prescribed amount is finished even if symptoms disappear after a few days. Stopping the medication too early may allow bacteria to continue to grow which may result in a relapse of the infection. Buy Curam Suspension Augmentin and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Curam Suspension Augmentin: Product Type: Prescription Drugs 5 Curam Suspension ( Augmentin Generic Amoxicillin/clavulanic acid ) Curam Suspension (Augmentin Generic Amoxicillin/clavulanic acid) Augmentin Generic Amoxicillin/clavulanic acid 125mg 250mg 300mL(3 x 100mL) 100mL Augmentin Generic Amoxicillin/clavulanic acid Curam Suspension
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
